NGAL/NGALR status | Mean survival time (months) | Percentage of 5-year survival (95% CI) | p Value |
Univariate | |||
–/– | 66.4 | 52.2% (7 to 102) | 0.048* |
–/+ or +/– | 50.5 | 37.5% (4 to 101) | |
+/+ | 49.8 | 40.9% (4 to 97) | |
Multivariate | |||
HR | 95% CI | p Value | |
Differentiation grade | 1.771 | 1.2 to 2.7 | 0.009** |
Location | 0.559 | 0.3 to 0.9 | 0.018* |
TNM stage | 3.150 | 1.9 to 5.2 | 0.000** |
NGAL/NGALR status | 1.432 | 1.0 to 1.9 | 0.026* |
NGAL/NGALR status: −, scores of 0–4, +, scores of 5–12.
*p<0.05; **p<0.01.
TNM, tumour, node, metastasis.